Key Updates
Executive summary: Boeing shares rose 2.10% since the October 7 report, closing at $190.83, as a Bloomberg opinion piece characterized the resolution of the 737 Max software glitch, a new NASA Starliner mandate, and a labor agreement with unionized workers as a "turning point" that reinforces the defense-led recovery narrative established by the F/A-XX and F-47 fighter contracts. While near-term sentiment has improved, the stock remains down 12.11% YTD and has not reclaimed the levels seen prior to the September 28 FAA software disclosure, leaving the investment thesis unchanged: defense momentum is real, but commercial delivery execution remains the swing factor for valuation.
Current Trend
Boeing is down 12.11% YTD, with a 6-month decline of 13.28% and a 1-month decline of 7.55%, reflecting the September 28-29 FAA software disclosure that triggered a 6% single-day drop to $184 and a 5.35% DJIA-worst session on September 16. Since then, shares have partially recovered on defense contract news (September 30 to October 7) and the October 7 "turning point" commentary, up 2.10% since the last report to $190.83. The 1-day move of +1.64% suggests renewed buying interest, though the 5-day figure of -1.41% indicates the recovery has not been linear. Key support sits near $184-187 (September lows and October 6-7 closing range), while resistance is near $198-200 (September 16 pre-glitch level) and the YTD high implied by the 6-month decline.
Investment Thesis
Boeing's investment case rests on two pillars: (1) a defense segment re-rating driven by sixth-generation fighter wins (F-47 and F/A-XX), which position the company as the sole provider of next-generation tactical aircraft and could generate "hundreds of billions of dollars" over program lifetimes per Reuters; and (2) a commercial aircraft recovery dependent on 737 Max delivery ramp-up and cash flow per plane, as emphasized by JPMorgan. Market-wide tailwinds include structurally favorable narrow-body demand growth versus wide-body, per Morningstar. The key company-specific risk remains execution on fixed-price development contracts, which have historically generated $20.5 billion in losses across five programs, and regulatory/certification risk on the 737 Max line.
Thesis Status
The thesis is intact but has shifted toward a more balanced risk profile. The defense-win narrative continues to strengthen (two fighter contracts secured within roughly six months), and the October 7 Bloomberg piece suggests the commercial-side overhang (737 Max software glitch) has been resolved, removing a near-term catalyst for further downside. However, the stock has not fully recovered the ~6% single-day loss from September 28-29, indicating the market has not yet fully priced in resolution of the software issue or is awaiting confirmation of delivery timelines. JPMorgan's view that commercial cash flow per plane—not defense headlines—will be the "most meaningful financial development" remains the critical watch item, and this has not yet been addressed by hard delivery data in the provided news flow.
Key Drivers
New developments since the October 7 report include: resolution of the 737 Max software issue, NASA's renewed commitment to the Starliner program, and a labor agreement with unionized workers, all cited together as a "turning point" by Bloomberg. This follows the September 30 F/A-XX Navy contract win (Reuters, WSJ), described by RBC as a "near-complete reversal" of Boeing's defense trajectory (Morningstar). This offsets the September 28-29 FAA certification delay on the 737 Max 10, which affected 801 delivered aircraft and over 70% of Boeing's order backlog (Financial Times, Bloomberg).
Technical Analysis
Boeing trades at $190.83, up 1.64% on the day and up 2.10% since the last report, but remains in a broader downtrend with 1-month (-7.55%) and 6-month (-13.28%) losses. The stock is attempting to stabilize above the $184-187 support zone established during the late-September selloff, with the next resistance around $198-200, the pre-glitch trading level from mid-September. The pattern suggests a recovery attempt within a still-negative medium-term trend; a sustained break above $198 would be needed to confirm a reversal, while a drop below $184 would retest the six-month lows.
Bull Case
- Boeing secured both major next-generation fighter contracts (F-47 Air Force, F/A-XX Navy), positioning it as the sole sixth-generation aircraft provider and potentially generating hundreds of billions in lifetime production value: Reuters
- Convergence of positive catalysts—737 Max software issue resolution, NASA Starliner program renewal, and a labor agreement—signals a broad-based operational turning point: Bloomberg
- RBC Capital Markets describes the Navy contract as a "near-complete reversal" of a previously credible risk that Boeing could exit fighter-jet production altogether: Morningstar
- Stock registered immediate positive price reactions to contract announcements (+1.78% and nearly +2% premarket), indicating constructive investor sentiment toward defense wins: WSJ
- Structural demand growth favors Boeing's narrow-body portfolio, with worldwide narrow-body sales outpacing wide-body sales over the past 20 years amid low-cost carrier and emerging-market demand: Morningstar
Bear Case
- JPMorgan analysts emphasize that defense wins are secondary to the "most meaningful financial development"—improving commercial aircraft production and cash flow per plane at Boeing Commercial Airplanes—which remains unresolved: Morningstar
- The FAA's certification delay on the 737 Max 10 impacted 801 delivered aircraft and over 70% of Boeing's total order backlog, posing a significant setback to commercial recovery: Financial Times
- Fixed-price development contracts carry significant financial risk, having already generated $20.5 billion in losses across five programs; analysts caution the new fighter contracts' profitability depends heavily on final contract terms: Reuters
- The stock suffered its worst single-day percentage decline since October 2025 and was the worst DJIA performer following the software glitch disclosure, with declines in six of seven trading days: Morningstar
- Despite recent recovery, shares remain down 12.11% YTD and historically down 54.95% from their all-time closing high of $440.62 (March 2019), underscoring the scale of unresolved structural challenges: Morningstar